Taken together, our results showed that high expression of CBP was correlated with poor prognosis in patients with ovarian cancer, and knockdown of CBP inhibited tumor growth, promoted chemo-sensitivity, and attenuated UPR in ovarian cancer cells. This evidence concerns the gene CREBBP and ovarian cancer.